Novo Nordisk A/S ADR buy BMO Capital Markets
Start price
25.06.24
/
50%
€137.00
Target price
25.06.25
€152.14
Performance (%)
-8.39%
Price
12:19
€125.50
Summary
This prediction is currently active. With a performance of -8.39%, the BUY prediction for Novo Nordisk A/S ADR by BMO_Capital_Markets is down slightly. This prediction currently runs until 25.06.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Novo Nordisk A/S ADR | -0.385% |
iShares Core DAX® | 1.776% |
iShares Nasdaq 100 | -1.037% |
iShares Nikkei 225® | -0.335% |
iShares S&P 500 | 0.854% |
Comments by BMO_Capital_Markets for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $163.00 price target on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€119.50
12.04.24
12.04.24
€153.17
12.04.25
12.04.25
4.60%
12:19
12:19